Céline Montavon Sartorius

7PUBLICATIONS
26CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Oct 25, 2024
The Importance of Patient-Reported Outcome Measures (PROMs) in Oncological Vulvoperineal Defect Reconstruction: A Systematic Review.

Nicole E Speck, Julia Stoffel, Séverin Wendelspiess

|Jun 27, 2024
Perforator versus Non-Perforator Flap-Based Vulvoperineal Reconstruction-A Systematic Review and Meta-Analysis.

Séverin Wendelspiess, Loraine Kouba, Julia Stoffel

|Mar 28, 2024
Management of Patients with Hypersensitivity to Platinum Salts and Taxane in Gynecological Cancers: A Cross-Sectional Study by the European Network of Young Gynaecologic Oncologists (ENYGO).

Tibor A Zwimpfer, Esra Bilir, Khayal Gasimli

|Dec 23, 2023
Desensitization in patients with hypersensitivity to platinum and taxane in gynecological cancers.

Tibor A Zwimpfer, Kathrin Scherer, Andreas Schötzau

|Nov 26, 2022
Hormone Receptor Expression in Primary and Recurrent High-Grade Serous Ovarian Cancer and Its Implications in Early Maintenance Treatment.

Marcus Vetter, Sylvia Stadlmann, Evelyne Bischof

|Nov 02, 2019
Nivolumab in chemotherapy-resistant cervical cancer: report of a vulvitis as a novel immune-related adverse event and molecular analysis of a persistent complete response.

Florence Baettig, Tatjana Vlajnic, Marcus Vetter

Pageof 2

Frequent Collaborators

2 joint publications

Andreas Schötzau

2 joint publications

Viola Heinzelmann-Schwarz

2 joint publications

Marcus Vetter

2 joint publications

Christian Appenzeller-Herzog